Analyst Rating Update on Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX) : 9 brokerage houses believe that Becton Dickinson and Company (BDX) is a Strong Buy at current levels. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Becton Dickinson and Company (BDX). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 14 Wall Street Analysts endorse the stock as a Buy with a rating of 1.71.

Becton Dickinson and Company (BDX) : 11 investment research analysts covering Becton Dickinson and Company (BDX) have an average price target of $183.64 for the near short term. The highest target price given by the Brokerage Firm to the stock is $200 and the lowest target is $169 for the short term. Analysts expect the variance to be within $9.24 of the average price.

For the current week, the company shares have a recommendation consensus of Buy.


Becton Dickinson and Company (NYSE:BDX): The stock opened at $176.64 on Wednesday but the bulls could not build on the opening and the stock topped out at $176.75 for the day. The stock traded down to $175.09 during the day, due to lack of any buying support eventually closed down at $175.78 with a loss of -0.37% for the day. The stock had closed at $176.43 on the previous day. The total traded volume was 1,273,184 shares.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.